Viveve Medical Profit Margin

Viveve Medical (VIVE) currently reports a profit margin of -350.4% as of September 2022. That compares with -306.79% in the prior-year period — down 14.2% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore Viveve Medical's profit margin history and peer comparisons.

Viveve Medical's profit margin decreased from -306.79% to -350.4% — a 14.2% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Viveve Medical's profit margin of -350.4% is lower than the Healthcare sector average of 13.76%. That is roughly 2646.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Viveve Medical's current -350.4% should be judged against Healthcare norms (sector average: 13.76%) and against VIVE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -350.4%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for Viveve Medical, and consider following VIVE for alerts when major investors trade the stock.